Andere talen MDxHealth SA

Aandelen

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,39 ^USD	+0,84%		-9,13%	-39,34%

01/05	MDxHealth SA rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
01/05	Transcript : MDxHealth SA, Q1 2024 Earnings Call, May 01, 2024

MDxHealth : REGISTRATION RIGHTS AGREEMENT Form 6 K	20/06
MDxHealth : Extraordinary GENERAL MEETING Form 6 K	05/06
MDxHealth : Financial Reports	16/05
MDxHealth : Financial Reports	16/05
Mdxhealth to Present at Upcoming Investor Conferences	15/05
MDxHealth : CEO PURCHASES SHARES OF MDXHEALTH - Form 6-K	06/05
MDxHealth : Financial Reports	02/05
MDxHealth SA Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
Earnings Flash (MDXH) MDXHEALTH Posts Q1 Revenue $19.8M	01/05
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed	01/05
MDxHealth SA Revises Earnings Guidance for the Year 2024	01/05
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	12/03
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	12/03
MDxHealth SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	06/03
Earnings Flash (MDXH) MDXHEALTH Posts Q4 Revenue $19.4M	06/03
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results	06/03
MDxHealth SA Maintains Earnings Guidance for the Year 2024	06/03
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6	21/02
Mdxhealth Announces Resignation of Board Member	16/02
MDxHealth SA Announces Jan Pensaert Steps Down from its Board of Directors	16/02

Geen resultaten voor deze zoekopdracht